Max India Limited, a prominent player in the Indian healthcare and allied sectors, has successfully raised ₹80.35 crore through a preferential issue of convertible warrants. The company's Board of Directors approved the allotment of 36,19,594 fully convertible warrants at ₹222 per warrant on September 24, 2025.

Warrant Allotment Details

The allotment includes both promoter and non-promoter entities, with the following breakdown:

Key Points of the Preferential Issue

• Total Warrants Issued: 36,19,594
• Issue Price: ₹222 per warrant
• Total Amount Raised: ₹80,35,49,868

Warrant Conversion and Lock-in Period

Each warrant is convertible into one fully paid-up equity share of ₹10 upon payment of the remaining 50% consideration. The allotted securities are subject to lock-in restrictions as per the Securities and Exchange Board of India (SEBI) regulations.

Initial Payment and Future Conversion

Max India has received 50% of the total consideration, amounting to ₹40,17,74,934, at the time of allotment. The balance 50% will be payable upon conversion of the warrants into equity shares.

Regulatory Compliance

The preferential issue was conducted in accordance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has duly informed the BSE Limited and the National Stock Exchange of India Limited about the allotment.

This strategic move by Max India Limited is expected to strengthen its financial position and support its growth initiatives in the healthcare sector. The participation of both promoter and non-promoter entities in this preferential issue demonstrates confidence in the company's future prospects.

Max India Limited , a prominent player in the Indian healthcare and insurance sectors, has announced plans to shift its registered office from Maharashtra to the National Capital Territory (NCT) of Delhi. The company has initiated the process by publishing newspaper advertisements seeking public objections to this proposed change.

Key Details of the Relocation

Regulatory Compliance

The company is adhering to the regulatory requirements for such a move. As per the notice:

1. The relocation requires amendments to the company's Memorandum of Association.
2. Max India has filed an application with the Central Government under Section 13 of the Companies Act, 2013.
3. The company is seeking confirmation of the alteration of its Memorandum of Association in terms of the special resolution passed.

Impact on Stakeholders

Stakeholders, including creditors and the general public, have been invited to submit their objections, if any, within the stipulated timeframe. Objections can be filed through the following channels:

• MCA-21 portal ( www.mca.gov.in ) by filing an investor complaint form
• Registered post to the Regional Director, Western Region, at the provided address

Corporate Governance

This move demonstrates Max India's commitment to transparency and compliance with regulatory norms. By publicly announcing the proposed change and inviting objections, the company is ensuring that all stakeholders have an opportunity to voice their concerns.

Next Steps

The company will proceed with the relocation process after the objection period ends, subject to necessary approvals from the Central Government and addressing any valid objections received.

Max India Limited's decision to relocate its registered office to Delhi could be seen as a strategic move, potentially aligning the company more closely with the regulatory and business environment of the national capital. Stakeholders and interested parties should keep an eye on further announcements from the company regarding the progress of this relocation.